PTM | Disease association | Participants | Biological role | Regulation of LLPS | References |
---|---|---|---|---|---|
Ubiquitination | Non-small-cell lung cancer | USP42 | Drives nuclear speckle mrna splicing and promote tumorigenesis | Promotion | [8] |
Multiple cancer types | p62 | Promotes tumor cell survival by upregulating p62 liquid droplet formation and degradation | Promotion | [103] | |
Multiple cancer types | SPOP/DAXX | Co-localizes with DAXX in Liquid Nuclear Organelles and facilitates DAXX Ubiquitination | Promotion | [104] | |
Phosphorylation | Multiple cancer types | TAZ | Formation of transcription compartment to promote gene expression | Promotion | [68] |
Methylation | Leukaemia | YTHDC1-m6A condensates | Facilitates a phase-separated nuclear body and suppresses myeloid leukemica differentiation | Promotion | [105] |
Multiple cancer types | UTX (namely KDM6A) | Involved in chromatin-regulatory activity in tumour suppression | Promotion | [106] | |
Sumoylation | Colon cancer | RNF168 | Genomic instability and DNA damage repair | Promotion | [107] |
Acetylation | Multiple cancer types | KAT8-IRF1 | KAT8-IRF1 condensate formation boosts PD-L1 transcription | Promotion | [108] |
Neddylation | Acute promyelocytic leukemia (APL) | PML/RARa | Induce abberent LLPS and disrupt function of PML nuclear bodies to drive APL | Inhibition | [109] |